<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04133402</url>
  </required_header>
  <id_info>
    <org_study_id>2017_89</org_study_id>
    <secondary_id>2018-A01609-46</secondary_id>
    <nct_id>NCT04133402</nct_id>
  </id_info>
  <brief_title>Fertility After Intrauterine Tamponing Balloon: Where Are we</brief_title>
  <acronym>FERTIBTIU</acronym>
  <official_title>Evaluation of Fertility of Patients With a History of Postpartum Hemorrhage, Complicating Low-dose Delivery With Intrauterine Tamponade Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Today, few data are available on the patient's fertility following intrauterine tamponade
      balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several
      studies have concluded that there are no fertility disorders after conservative surgical
      treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim
      was to evaluate post-BTIU fertility and the appearance of gynecological symptoms.

      This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017.
      The data will be collected by telephone interview on fertility and various gynecological
      functional symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 19, 2019</start_date>
  <completion_date type="Actual">December 27, 2019</completion_date>
  <primary_completion_date type="Actual">December 27, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of infertility</measure>
    <time_frame>7 years</time_frame>
    <description>defined as the absence of pregnancy after 12 months of attempted pregnancy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to obtain a new pregnancy evaluating the stop of contraceptionand desire for pregnancy</measure>
    <time_frame>7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of gynecological complications after use of an intrauterine tamponade balloon.</measure>
    <time_frame>7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of gynecological complications after use of an intrauterine tamponade balloon.</measure>
    <time_frame>7 years</time_frame>
    <description>type = infections , pelvic pain, cycle disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the frequency of obstetric complications for the next pregnancy</measure>
    <time_frame>7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of obstetrical complications</measure>
    <time_frame>7 years</time_frame>
    <description>complications = intrauterine growth retardation, threat of premature labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of recurrent postpartum haemorrhage in the next pregnancy</measure>
    <time_frame>7 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">59</enrollment>
  <condition>Hemorrhage Postpartum</condition>
  <condition>Fertility Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Major patients with postpartum haemorrhage after vaginal delivery between 2012 and 2017 in
        Valenciennes maternity and the CHRU Lille, treated by intrauterine tamponade therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Vaginal birth

          -  Post partum haemorrhage

          -  Intrauterine tamponing balloon

          -  Between 2012 and 2017

          -  CHRU Lille and CH Valenciennes

        Exclusion Criteria:

          -  Minor patients

          -  Initial intake started in another center (postpartum transfer).

          -  Refusal to participate in the study

          -  Invasive treatments for postpartum haemorrhage

          -  Caesarean
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Garabedian, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HÃ´pital Roger Salengro, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 17, 2019</study_first_submitted>
  <study_first_submitted_qc>October 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2019</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemorrhage Post-partum</keyword>
  <keyword>Fertility</keyword>
  <keyword>Uterine balloon tamponade</keyword>
  <keyword>Vaginal Birth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postpartum Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

